ArticleBMJ open respiratory research2022

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis.

Steven D Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.